← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Viral Genomix, Inc.
Blue Bell, PA
$25,086,491
Total funding
4
Grants
Funding over time
peak $6.6M · FY2005–13$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$25,086,491 · 4
By mechanism
N01$23,679,776 · 1
R43$1,406,715 · 3
Investigators at Viral Genomix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$6,573,776
N01 · FY2009 · AI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$5,258,144
N01 · FY2010 · AI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$4,663,588
N01 · FY2008 · AI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$3,342,566
N01 · FY2011 · AI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$2,529,017
N01 · FY2012 · AI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$1,312,685
N01 · FY2013 · AI
Preclin. Test of Biodefense Drug for SEB Toxin Exposure$640,895
R43 · FY2006 · AI
Preclinical Test of Biodefense Drug for SEB Toxin$575,618
R43 · FY2005 · AI
Development of New Agent to Treat Toxin Induced Sepsis$99,940
R43 · FY2003 · AI
Testing of a New Protein Drug for Toxin-Induced Sepsis$90,262
R43 · FY2003 · AI